Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Non-Current Assets: 2022-2025

Historic Other Non-Current Assets for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $407,000.

  • Gossamer Bio's Other Non-Current Assets rose 43.82% to $407,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $407,000, marking a year-over-year increase of 43.82%. This contributed to the annual value of $283,000 for FY2024, which is 54.21% down from last year.
  • Gossamer Bio's Other Non-Current Assets amounted to $407,000 in Q3 2025, which was up 6.27% from $383,000 recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Other Non-Current Assets ranged from a high of $1.3 million in Q2 2022 and a low of $59,000 during Q2 2024.
  • Its 3-year average for Other Non-Current Assets is $465,273, with a median of $407,000 in 2025.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first slumped by 92.34% in 2024, then soared by 549.15% in 2025.
  • Over the past 4 years, Gossamer Bio's Other Non-Current Assets (Quarterly) stood at $680,000 in 2022, then fell by 9.12% to $618,000 in 2023, then crashed by 54.21% to $283,000 in 2024, then soared by 43.82% to $407,000 in 2025.
  • Its last three reported values are $407,000 in Q3 2025, $383,000 for Q2 2025, and $310,000 during Q1 2025.